Concerning ovarian cancer (Table 4), a significant increase in the risk was found for heterozygous ERCC2 Lys751Gln and who had menarche before 13 years old (OR = 6.03; 95% CI = 1.02–35.78). This evidence concerns the gene ERCC2 and ovarian cancer.